Meineke I - Search Results

1

Modelling of residual variability in toxicokinetic studies with sparse sampling: the case of tetrahydronaphthalene.

Meineke I, Eisele J, Certa H, Gundert-Remy UM. Meineke I, et al. Arch Toxicol. 1998 Dec;72(12):807-10. doi: 10.1007/s002040050577. Arch Toxicol. 1998. PMID: 9950078

2

Modelling of non-linear pharmacokinetics in sheep after short-term infusion of cardiotoxic doses of imipramine.

Meineke I, Schmidt W, Nottrott M, Schröder T, Hellige G, Gundert-Remy U. Meineke I, et al. Pharmacol Toxicol. 1997 Jun;80(6):266-71. doi: 10.1111/j.1600-0773.1997.tb01972.x. Pharmacol Toxicol. 1997. PMID: 9225362

3

Pharmacokinetics and pharmacodynamics of candesartan after administration of its pro-drug candesartan cilexetil in patients with mild to moderate essential hypertension--a population analysis.

Meineke I, Feltkamp H, Högemann A, Gundert-Remy U. Meineke I, et al. Eur J Clin Pharmacol. 1997;53(3-4):221-8. doi: 10.1007/s002280050366. Eur J Clin Pharmacol. 1997. PMID: 9476035 Clinical Trial.

4

An inexpensive and sensitive method for the determination of quinidine in plasma by high-performance liquid chromatography with ultraviolet detection.

Meineke I, Rohde S, Gundert-Remy U. Meineke I, et al. Ther Drug Monit. 1995 Feb;17(1):75-8. doi: 10.1097/00007691-199502000-00012. Ther Drug Monit. 1995. PMID: 7725381

5

Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes.

Löser SV, Meyer J, Freudenthaler S, Sattler M, Desel C, Meineke I, Gundert-Remy U. Löser SV, et al. Among authors: meineke i. Naunyn Schmiedebergs Arch Pharmacol. 1996 Jul;354(2):192-7. doi: 10.1007/BF00178720. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8857597

6

Concentration-effect relationship of the positive chronotropic and hypokalaemic effects of fenoterol in healthy women of childbearing age.

Bouillon T, Meineke I, Port R, Hildebrandt R, Günther K, Gundert-Remy U. Bouillon T, et al. Among authors: meineke i. Eur J Clin Pharmacol. 1996;51(2):153-60. doi: 10.1007/s002280050177. Eur J Clin Pharmacol. 1996. PMID: 8911881 Clinical Trial.

7

Non-response to maprotiline caused by ultra-rapid metabolism that is different from CYP2D6?

Vormfelde SV, Bitsch A, Meineke I, Gundert-Remy UM, Gleiter CH. Vormfelde SV, et al. Among authors: meineke i. Eur J Clin Pharmacol. 1997;52(5):387-90. doi: 10.1007/s002280050306. Eur J Clin Pharmacol. 1997. PMID: 9272409

8

Routine measurement of fluoxetine and norfluoxetine by high-performance liquid chromatography with ultraviolet detection in patients under concomitant treatment with tricyclic antidepressants.

Meineke I, Schreeb K, Kress I, Gundert-Remy U. Meineke I, et al. Ther Drug Monit. 1998 Feb;20(1):14-9. doi: 10.1097/00007691-199802000-00003. Ther Drug Monit. 1998. PMID: 9485548

9

Determination of 2-hydroxyphenylacetic acid (2HPAA) in urine after oral and parenteral administration of coumarin by gas-liquid chromatography with flame-ionization detection.

Meineke I, Desel H, Kahl R, Kahl GF, Gundert-Remy U. Meineke I, et al. J Pharm Biomed Anal. 1998 Jul;17(3):487-92. doi: 10.1016/s0731-7085(97)00224-0. J Pharm Biomed Anal. 1998. PMID: 9656160

10

Influence of urine pH and urinary flow on the renal excretion of memantine.

Freudenthaler S, Meineke I, Schreeb KH, Boakye E, Gundert-Remy U, Gleiter CH. Freudenthaler S, et al. Among authors: meineke i. Br J Clin Pharmacol. 1998 Dec;46(6):541-6. doi: 10.1046/j.1365-2125.1998.00819.x. Br J Clin Pharmacol. 1998. PMID: 9862242 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters